Maurice Slevin
Dr. Maurice Slevin is a British oncologist and researcher, originally from South Africa.
He is known as a researcher into the schedule dependency of chemotherapy as well as for carrying out research in psychosocial oncology. He joined Doctor Vicky Clement-Jones in setting up Cancerbackup[1][2], a U.K. cancer charity in 1985 and chaired the charity for over 20 years. He is also a founding partner and board member of Leaders in Oncology Care (formerly called London Oncology Clinic).
Contents
Education and background
In 1973, Dr. Slevin graduated from the University of Cape Town (South Africa) with a MbChB degree. He completed his internal medicine registrar training at Groot-Schuur Hospital in Cape Town.
Dr. Slevin pursued an MRCP postgraduate degree in London (earned in 1978) and undertook his oncology registrar training at St. Bartholomew’s and Homerton Hospitals in London. He obtained his Specialist Accreditation in Medical Oncology in 1982.
He carried out a research doctorate in clinical pharmacology and was awarded an MD from the University of Cape Town, graduating in 1984.
Career
Upon obtaining specialist accreditation in Medical Oncology in 1982, Dr. Slevin became as a consultant medical oncologist for the UK's National Health Service at St. Bartholomew’s Hospital and Homerton Hospital, he specialised in breast, ovarian, lung and gastrointestinal cancers.
Dr. Slevin also became a Fellow of the Royal College of Physicians of London (FRCP) designation (1989) while he was working at the National Health Service.
In 2005, Dr. Slevin co-founded Leaders in Oncology Care (LOC), which started out in London and now has seven practice locations with more than 70 oncology specialists. LOC is now majority-owned by Healthcare Corporate America (HCA).
Cancer research
While working as a consultant medical oncologist at St Bartholomews and Homerton Hospitals, Dr. Slevin founded and directed a clinical pharmacology laboratory investigating schedule dependency in chemotherapy for small-cell lung cancer[3].
He also conducted research on the clinical pharmacology of cytosine arabinoside and etoposide[4], and also performed early research on morphine’s major active metabolites. Dr. Slevin also conducted research on attitudes to chemotherapy among post-diagnosis cancer patients[5].
Dr. Slevin also supervised several doctoral students while he was at the NHS.
Cancerbackup and Cancer Research Campaign
In 1985, Dr. Slevin was a co-founder of Cancerbackup, assisting Dr Vicky Clement-Jones to set up the cancer charity, and was the board chairman from 1987 until 2008. In 2008, Cancerbackup merged with Macmillan Cancer Care. Dr Slevin was a trustee of Macmillan Cancer Care from 2008 to 2010.
Additionally, from 1995-2000, Dr. Slevin was a trustee of Cancer Research Campaign (CRC), a major funder based in the United Kingdom. He was also the chair of CRC’s education and psychosocial committee.
Criticism of the NHS
Starting in the early 2000s, Dr. Slevin has also criticised the way the NHS was managed. He published several articles about NHS management.[6][7][8]
According to Dr. Slevin, the NHS was hampered by excessive bureaucracy and red tape, and that there were nearly as many NHS managers as nurses. However, the NHS federation disagreed with Slevin's claims.[9] He also became the co-founder of Doctors for Reform[10], an organization that proposed reforms for the NHS, such as a social insurance funding model.
Publications
Dr. Slevin has edited 3 medical books and written 2 books for cancer patients.
He has also been the author or co-author of more than 150 peer reviewed publications, 11 editorials, and various book chapters.
H-index
His h-index is 56, per Google Scholar[11].
References
- ↑ (in en) BACUP--the first two years: evaluation of a national cancer information service, 1988-09-10, https://pubmed.ncbi.nlm.nih.gov/3140928/, retrieved 2021-11-26
- ↑ (in en) Cancerbackup: A brief history, https://www.macmillan.org.uk/documents/aboutus/whoweare/history/part4timeline.pdf, retrieved 2021-11-26
- ↑ (in en) A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer, 1989-09-07, https://pubmed.ncbi.nlm.nih.gov/2549204/, retrieved 2021-11-26
- ↑ (in en) Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid, 1983-09-01, https://pubmed.ncbi.nlm.nih.gov/6583325/, retrieved 2021-11-26
- ↑ (in en) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public, 1990-06-02, https://pubmed.ncbi.nlm.nih.gov/2379006/, retrieved 2021-11-26
- ↑ (in en) NHS could implode say doctors, 2003-02-03, http://news.bbc.co.uk/2/hi/health/2720143.stm, retrieved 2021-11-26
- ↑ (in en) NHS on brink of implosion, claims leading specialist, 2003-02-03, https://www.theguardian.com/society/2003/feb/04/NHS.politics, retrieved 2021-11-26
- ↑ (in en) NHS is crushed by red tape, consultants say, 2003-02-04, https://www.telegraph.co.uk/education/3307639/NHS-is-crushed-by-red-tape-say-consultants.html, retrieved 2021-11-26
- ↑ (in en) Managers fight back over consultants claims, 2003-02-06, https://www.publicfinance.co.uk/news/2003/02/managers-fight-back-over-consultants-claims, retrieved 2021-11-26
- ↑ (in en) Doctors for Reform, https://powerbase.info/index.php/Doctors_for_Reform, retrieved 2021-11-26
- ↑ (in en) Maurice Slevin on Google Scholar, https://scholar.google.com/citations?hl=en&user=jf_0bHgAAAAJ, retrieved 2021-11-26
